What will Johnson & Johnson say during their next earnings call?
$43,288 Umsatz
Jan 21, 2026
Nipocalimab / Lupus
$339 Umsatz
Yes
Nipocalimab / Lupus
$339 Umsatz
Yes
Halda Therapeutics / Haida Therapeutics
$4,472 Umsatz
Ja
Halda Therapeutics / Haida Therapeutics
$4,472 Umsatz
Ja
Darzalex Faspro
$266 Umsatz
No
Darzalex Faspro
$266 Umsatz
No
Ottava
$7,631 Umsatz
Yes
Ottava
$7,631 Umsatz
Yes
Vaccine
$7,002 Umsatz
No
Vaccine
$7,002 Umsatz
No
Procedure
$665 Umsatz
Yes
Procedure
$665 Umsatz
Yes
Europe
$568 Umsatz
Yes
Europe
$568 Umsatz
Yes
Carvykti
$355 Umsatz
Yes
Carvykti
$355 Umsatz
Yes
Rybrevant
$2,497 Umsatz
Yes
Rybrevant
$2,497 Umsatz
Yes
Trufill
$2,551 Umsatz
No
Trufill
$2,551 Umsatz
No
Administration
$16,687 Umsatz
Yes
Administration
$16,687 Umsatz
Yes
China
$254 Umsatz
Yes
China
$254 Umsatz
Yes
Regeln
This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
Erstellt am: Jan 12, 2026, 12:39 PM ET
Volumen
$43,288Enddatum
Jan 21, 2026Erstellt am
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...Ergebnis vorgeschlagen: Yes
Kein Widerspruch
Endgültiges Ergebnis: Yes
What will Johnson & Johnson say during their next earnings call?
$43,288 Umsatz
Nipocalimab / Lupus
$339 Umsatz
Yes
Halda Therapeutics / Haida Therapeutics
$4,472 Umsatz
Ja
Darzalex Faspro
$266 Umsatz
No
Ottava
$7,631 Umsatz
Yes
Vaccine
$7,002 Umsatz
No
Procedure
$665 Umsatz
Yes
Europe
$568 Umsatz
Yes
Carvykti
$355 Umsatz
Yes
Rybrevant
$2,497 Umsatz
Yes
Trufill
$2,551 Umsatz
No
Administration
$16,687 Umsatz
Yes
China
$254 Umsatz
Yes
Über
Volumen
$43,288Enddatum
Jan 21, 2026Erstellt am
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...Vorsicht vor externen Links.
Vorsicht vor externen Links.

Vorsicht vor externen Links.
Vorsicht vor externen Links.